Literature DB >> 14625694

Suppression of TGF-beta signaling by conophylline via upregulation of c-Jun expression.

S Atsumi1, A Nagasawa, T Koyano, T Kowithayakornd, K Umezawa.   

Abstract

In the course of screening for inhibitors of transforming-growth factor-beta (TGF-beta) functions we found that conophylline, a vinca alkaloid, inhibited TGF-beta-induced apoptosis in rat hepatoma cells. Because conophylline also inhibited TGF-b-induced promoter activity in mink lung cells, we studied the mechanism of the inhibition in this cell line. Conophylline did not inhibit nuclear translocation of Smad2. Instead, we found that conophylline increased the expression of c-Jun, which had been earlier shown to interact with the corepressor TGIF to suppress the transcriptional activity dependent on Smad2. Conophylline attenuated the interaction between the Smad2 complex and p300 but enhanced that between the Smad2 complex and TGIF. In cells overexpressing c-Jun, suppression of promoter activity induced by TGF-beta and the enhancement of the association of the Smad2 complex with TGIF were also observed. Thus, our data suggest that inhibition of TGF-beta-induced promoter activity by conophylline can be attributed to its potency in modulating the interaction of downstream transcriptional factors via upregulation of c-Jun expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625694     DOI: 10.1007/s00018-003-3299-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  5 in total

Review 1.  Screening of new bioactive metabolites for diabetes therapy.

Authors:  Kulrawee Sidthipong; Satoru Todo; Izumi Takei; Itaru Kojima; Kazuo Umezawa
Journal:  Intern Emerg Med       Date:  2013-04       Impact factor: 3.397

2.  The plant alkaloid conophylline inhibits matrix formation of fibroblasts.

Authors:  Takehiko Tezuka; Akinobu Ota; Sivasundaram Karnan; Katsuhiko Matsuura; Kazuhisa Yokoo; Yoshitaka Hosokawa; Davide Vigetti; Alberto Passi; Sonoko Hatano; Kazuo Umezawa; Hideto Watanabe
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

3.  Conophylline inhibits non-alcoholic steatohepatitis in mice.

Authors:  Yukiomi Nakade; Kazumasa Sakamoto; Taeko Yamauchi; Tadahisa Inoue; Yuji Kobayashi; Takaya Yamamoto; Norimitsu Ishii; Tomohiko Ohashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Yoshitaka Fukuzawa; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 4.  Cellular Signal Transductions and Their Inhibitors Derived from Deep-Sea Organisms.

Authors:  Liyan Wang; Kazuo Umezawa
Journal:  Mar Drugs       Date:  2021-04-05       Impact factor: 5.118

5.  Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice.

Authors:  Tomohiko Ohashi; Yukiomi Nakade; Mayu Ibusuki; Rena Kitano; Taeko Yamauchi; Satoshi Kimoto; Tadahisa Inoue; Yuji Kobayashi; Yoshio Sumida; Kiyoaki Ito; Haruhisa Nakao; Kazuo Umezawa; Masashi Yoneda
Journal:  PLoS One       Date:  2019-01-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.